2026 Marijuana Stocks To Watch As The Sector Begins To Change
In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. While 2025 seemed to be a transition year, 2026 could mark another pivot point. Specifically, one where improved business operations begin to consistently translate into stronger equity valuations across the sector. Investor sentiment may also shift meaningfully.
Reduced federal risk and improved earnings quality could attract longer-term institutional investors. Those who previously avoided the sector due to the high risk that most cannabis stocks bring. While full federal legalization and banking reform may still be unresolved, cannabis stocks in 2026 are more likely to trade on business performance rather than headline-driven speculation. For marijuana stock investors, 2026 favors patience and discipline.
The sector’s upside will increasingly belong to companies that execute well and manage capital responsibly. As well as prove they can operate as durable consumer and healthcare businesses, not just regulatory trades. Right now, investors are prepping for the new year and what’s next to come. More states are set to vote on legalizing cannabis in addition to other regulatory matters. Below are several marijuana stocks to watch as things begin to ramp for the 2026 trading year.
Top Marijuana Stocks To Watch Now
- Tilray Brands, Inc. (NASDAQ:TLRY)
- Cronos Group Inc.(NASDAQ:CRON)
- Aurora Cannabis Inc.(NASDAQ:ACB)
Tilray Brands, Inc.
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. 
In recent news, the company announced that on January 8th, it will report its second quarter fiscal Year 2026.
Cronos Group Inc.
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. In early December, the company announced it had entered the Netherlands cannabis market. 
This came to be with the acquisition of Europe’s largest adult-use cannabis company. So Cronos has entered into a definitive share sale and purchase agreement to acquire all of the outstanding shares of CanAdelaar B.V.
Words From The Company
“Our acquisition of CanAdelaar is a financially compelling and highly strategic transaction that will establish a strategic footprint in Europe and enable us to leverage our investments in borderless products,” said Mike Gorenstein, Chairman, President and CEO of Cronos.”
[Read More] Best U.S. Cannabis Penny Stocks to Trade Now With Rescheduling Momentum
Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. 
On December 18th, the company launched the Daily Special in Germany. This new product delivers high-quality and affordable medical cannabis to patients.
[Read More] 3 Top Marijuana Stocks After Cannabis Gets Rescheduled
Words From The Senior Vice President
“The launch of Daily Special in Germany is a clear demonstration of Aurora’s long-term investment and leadership in one of the world’s most important medical cannabis markets and key region for the company,” said, Andreas Dotterweich, Senior Vice President, Aurora Europe.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
